Intellia Therapeutics, Inc. short interest in 2025
In 2025, Intellia Therapeutics, Inc.'s disclosed short interest ran from 23.62% of shares outstanding on 15 Jan 2025 to 35.88% on 31 Dec 2025, a change of +12.26 percentage points. The year's high was 38.48% on 28 Nov 2025 and its low 23.59% on 14 Feb 2025, averaging 28.93% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 13.73 days on 31 Dec 2025. Full history: Intellia Therapeutics, Inc..
Cite this page
By year: 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026
2025 in figures
- Start of year
- 23.62% (15 Jan 2025)
- End of year
- 35.88% (31 Dec 2025)
- Change
- +12.26 pp
- High
- 38.48% (28 Nov 2025)
- Low
- 23.59% (14 Feb 2025)
- Average
- 28.93%
- Highest days to cover
- 13.73 (31 Dec 2025)
- SEC filings marked
- 9
Every report in 2025
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 15 Jan 2025 | 23.62% | 7.26 | results (8-K) |
| 31 Jan 2025 | 23.62% | 8.18 | |
| 14 Feb 2025 | 23.59% | 9.38 | |
| 28 Feb 2025 | 25.15% | 6.07 | 10-K filed, results (8-K) |
| 14 Mar 2025 | 25.78% | 8.59 | |
| 31 Mar 2025 | 26.02% | 7.78 | |
| 15 Apr 2025 | 27.54% | 7.24 | |
| 30 Apr 2025 | 27.75% | 9.60 | |
| 15 May 2025 | 29.64% | 8.69 | 10-Q filed, results (8-K) |
| 30 May 2025 | 30.47% | 5.14 | |
| 13 Jun 2025 | 28.66% | 5.89 | |
| 30 Jun 2025 | 29.09% | 6.14 | |
| 15 Jul 2025 | 27.87% | 6.19 | |
| 31 Jul 2025 | 27.68% | 5.92 | |
| 15 Aug 2025 | 25.83% | 5.70 | 10-Q filed, results (8-K) |
| 29 Aug 2025 | 25.84% | 7.56 | |
| 15 Sep 2025 | 31.80% | 7.88 | |
| 30 Sep 2025 | 27.70% | 3.64 | |
| 15 Oct 2025 | 28.79% | 4.20 | |
| 31 Oct 2025 | 33.74% | 3.20 | |
| 14 Nov 2025 | 34.74% | 4.13 | 10-Q filed, results (8-K) |
| 28 Nov 2025 | 38.48% | 9.48 | |
| 15 Dec 2025 | 35.03% | 10.40 | |
| 31 Dec 2025 | 35.88% | 13.73 |
See also: Intellia Therapeutics, Inc.'s full history · most shorted US stocks of 2025 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.